Therefore, serum metabolites could be used to help with the early diagnosis of HCC patients who tested negative for AFP and the identification of microvascular invasion to aid in preoperative surgical planning and postoperative follow-up. The gene discussed is AFP; the disease is hepatocellular carcinoma.